SubHero Banner
Text

October 2018

Core topics in this month’s edition include:

  • Hyrimoz (adalimumab-adaz) - new biosimilar approval
  • Invokana (canagliflozin), Invokamet (canagliflozin/metformin), Invokamet XR (canagliflozin/metformin extended release) - new indication
  • Irbesartan - drug recall

Download PDF

Text